Bağırsak Gazı
Özet
Bağırsak gazı ve buna bağlı gelişen şişkinlik, geğirme ve karın ağrısı gibi yakınmalar, toplumda yaygın görülen ve yaşam kalitesini etkileyen önemli gastrointestinal sorunlar arasındadır. Normal bireylerde sindirim sisteminde yaklaşık 200 ml gaz bulunur ve bu gazın %99'undan fazlasını kokusuz olan azot, oksijen, karbondioksit, hidrojen ve metan oluşturur; kötü koku ise eser miktardaki kükürtlü bileşiklerden kaynaklanır. Gazın ana kaynakları hava yutma (aerofaji) ve bakteriyel fermantasyon yoluyla lümen içi üretimdir. Klinik olarak geğirme, gastrik ve supragastrik olarak ikiye ayrılırken; şişkinlik ve gerginlik ise genellikle irritabl bağırsak sendromu (IBS), çölyak hastalığı veya laktoz intoleransı gibi durumlarla ilişkilidir. Tanı aşamasında özellikle 50 yaş üstü başlangıç, kilo kaybı ve anemi gibi alarm semptomlarının varlığına dikkat edilmeli, bu semptomlar yoksa ileri tetkikten kaçınılmalıdır. Tedavi yaklaşımı öncelikle hasta eğitimi ve diyet değişikliklerini kapsar; özellikle fermente edilebilir karbonhidratları kısıtlayan düşük FODMAP diyeti, gaz ve şişkinlik semptomlarının azaltılmasında etkili bir yöntem olarak öne çıkar. Ayrıca yaşam tarzı değişiklikleri, diyafragmatik solunum ve gerekli durumlarda ilaç tedavisi semptom yönetiminde kritik rol oynar.
Intestinal gas and related complaints such as bloating, belching, and abdominal pain are common gastrointestinal issues that significantly impact quality of life. In healthy individuals, the digestive system contains approximately 200 ml of gas, with over 99% consisting of odorless nitrogen, oxygen, carbon dioxide, hydrogen, and methane; the unpleasant odor arises from trace sulfur compounds. The primary sources of gas are air swallowing (aerophagia) and intraluminal production via bacterial fermentation. Clinically, belching is categorized into gastric and supragastric types, while bloating and distension are often associated with conditions like irritable bowel syndrome (IBS), celiac disease, or lactose intolerance. During diagnosis, the presence of alarm symptoms such as onset after age 50, weight loss, and anemia must be monitored; in their absence, extensive testing should be avoided. The treatment approach primarily involves patient education and dietary modifications, where the low FODMAP diet, which restricts fermentable carbohydrates, stands out as an effective method for reducing gas and bloating symptoms. Additionally, lifestyle changes, diaphragmatic breathing, and pharmacological treatments when necessary play a critical role in symptom management.
Referanslar
Tekin. F. Turan İ.Musaoğlu A. 2011. Bağırsak gazları ve gazla ilgili sorunlar. Tankut İlter (95-108) İzmir. Güven Kitabevi.
Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975; 293:524.
BEDELL GN, MARSHALL R, DUBOIS AB, et al. HARRIS JH. Measurement of the volume of gas in the gastrointestinal tract; values in normal subjects and ambulatory patients. J Clin Invest 1956; 35:336.
Tomlin J, Lowis C, Read NW. Investigation of normal flatus production in healthy volunteers. Gut 1991; 32:665.
Koide A, Yamaguchi T, Odaka T, et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95:1735.
Moore JG, Jessop LD, Osborne DN. Gas-chromatographic and mass-spectrometric analysis of the odor of human feces. Gastroenterology 1987; 93:1321.
Suarez FL, Springfield J, Levitt MD. Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut 1998; 43:100.
Chitkara DK, Bredenoord AJ, Rucker MJ, et al. Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther 2005; 22:855.
Levitt MD. Intestinal gas production. J Am Diet Assoc 1972; 60:487.
Steggerda FR. Gastrointestinal gas following food consumption. Ann N Y Acad Sci 1968; 150:57.
Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med 1969; 281:122.
Olesen M, Rumessen JJ, Gudmand-Høyer E. Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test. Eur J Clin Nutr 1994; 48:692.
Wolin MJ. Fermentation in the rumen and human large intestine. Science 1981; 213:1463.
Gibson GR, Macfarlane GT, Cummings JH. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol 1988; 65:103.
Lajoie SF, Bank S, Miller TL, Wolin MJ. Acetate production from hydrogen and [13C]carbon dioxide by the microflora of human feces. Appl Environ Microbiol 1988; 54:2723.
Newcomer AD, McGill DB, Thomas PJ, et al. Hofmann AF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med 1975; 293:1232.
Florin TH, Woods HJ. Inhibition of methanogenesis by human bile. Gut 1995; 37:418.
MCNALLY EF, KELLY JE Jr, INGELFINGER FJ. MECHANISM OF BELCHING: EFFECTS OF GASTRIC DISTENSION WITH AIR. Gastroenterology 1964; 46:254.
Bredenoord AJ, Weusten BL, Sifrim D, et al. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 2004; 53:1561.
Bredenoord AJ, Smout AJ. Physiologic and pathologic belching. Clin Gastroenterol Hepatol 2007; 5:772.
Richter JE, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med 1982; 97:93.
Hemmink GJ, Bredenoord AJ, Weusten BL, et al. Supragastric belching in patients with reflux symptoms. Am J Gastroenterol 2009; 104:1992.
Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology 2016; 150:1380.
Disney B, Trudgill N. Managing a patient with excessive belching. Frontline Gastroenterol 2014; 5:79.
Katzka DA. Simple office-based behavioral approach to patients with chronic belching. Dis Esophagus 2013; 26:570.
Hemmink GJ, Ten Cate L, Bredenoord AJ, et al. Speech therapy in patients with excessive supragastric belching--a pilot study. Neurogastroenterol Motil 2010; 22:24.
Olsson S, Furne J, Levitt MD. Relationship of gaseous symptoms to intestinal gas production: Symptoms do not equal increased production. Gastroenterology 1995; 108 Suppl:A28.
de Roest RH, Dobbs BR, Chapman BA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013; 67:895.
Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146:67.
Friis H, Bodé S, Rumessen JJ, et al. Gudmand-Høyer E. Effect of simethicone on lactulose-induced H2 production and gastrointestinal symptoms. Digestion 1991; 49:227.
Hall RG Jr, Thompson H, Strother A. Effects of orally administered activated charcoal on intestinal gas. Am J Gastroenterol 1981; 75:192.
Jain NK, Patel VP, Pitchumoni S. Et al. Activated charcoal, simethicone, and intestinal gas: a double-blind study. Ann Intern Med 1986; 105:61.
Potter T, Ellis C, Levitt M. Activated charcoal: in vivo and in vitro studies of effect on gas formation. Gastroenterology 1985; 88:620.
Suarez FL, Furne J, Springfield J, Levitt MD. Failure of activated charcoal to reduce the release of gases produced by the colonic flora. Am J Gastroenterol 1999; 94:208.
Ganiats TG, Norcross WA, Halverson AL, et al. Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract 1994; 39:441.
Hillilä M, Färkkilä MA, Sipponen T, et al. Does oral α-galactosidase relieve irritable bowel symptoms? Scand J Gastroenterol 2016; 51:16.
Suarez FL, Furne JK, Springfield J, et al. Levitt MD. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology 1998; 114:923.
Ohge H, Furne JK, Springfield J, et al. Effectiveness of devices purported to reduce flatus odor. Am J Gastroenterol 2005; 100:397.
Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130:1480.
Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998; 42:690.
Tuteja AK, Talley NJ, Joos SK, et al. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol 2008; 103:1241.
Levitt MD. Volume and composition of human intestinal gas determined by means of an intestinal washout technic. N Engl J Med 1971; 284:1394.
Maxton DG, Martin DF, Whorwell PJ, et al. Godfrey M. Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. Gut 1991; 32:662.
Salvioli B, Serra J, Azpiroz F, et al. Origin of gas retention and symptoms in patients with bloating. Gastroenterology 2005; 128:574.
Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001; 48:14.
Serra J, Salvioli B, Azpiroz F, et al. Malagelada JR. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002; 123:700.
Caldarella MP, Serra J, Azpiroz F, et al. Malagelada JR. Prokinetic effects in patients with intestinal gas retention. Gastroenterology 2002; 122:1748.
Johnson AG. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. Br Med J 1971; 2:25.
Van Outryve M, Milo R, Toussaint J, et al. Van Eeghem P. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991; 13:49.
Schuster MM, Whitehead WE. Physiologic insights into irritable bowel syndrome. Clin Gastroenterol 1986; 15:839.
Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14:125.
Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131:445.
Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292:852.
Lewis MJ, Reilly B, Houghton LA, Whorwell PJ. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut 2001; 48:216.
Accarino A, Perez F, Azpiroz F, et al. Abdominal distention results from caudo-ventral redistribution of contents. Gastroenterology 2009; 136:1544.
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466.
Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016.
Villoria A, Serra J, Azpiroz F, Malagelada JR. Physical activity and intestinal gas clearance in patients with bloating. Am J Gastroenterol 2006; 101:2552.
Sullivan SN. Functional abdominal bloating with distention. ISRN Gastroenterol 2012; 2012:721820.
Schmulson M, Chang L. Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther 2011; 33:1071.
Barrett, J.S. (2013). Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutrıtıon In Clınıcal Practıce. 28(3):300-6, doi: 10.1177/0884533613485790
